Danaher Corporation (BIT:1DHR)

Market Cap	130.53B -24.3%
Revenue (ttm)	20.92B +2.9%
Net Income	3.08B -7.3%
EPS	4.30 -4.5%
Shares Out	n/a
PE Ratio	42.41
Forward PE	25.79
Dividend	0.82 (0.45%)
Ex-Dividend Date	Dec 23, 2025

Volume	n/a
Average Volume	13
Open	182.54
Previous Close	182.54
Day's Range	182.54 - 182.54
52-Week Range	156.26 - 206.70
Beta	n/a
RSI	35.66
Earnings Date	Jan 28, 2026

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man...

• Industry: Laboratory Analytical Instruments
• Founded: 1969
• Employees: 60,000
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1DHR

Financial Performance

In 2025, Danaher's revenue was $24.57 billion, an increase of 2.90% compared to the previous year's $23.88 billion. Earnings were $3.61 billion, a decrease of -7.31%.

Financial numbers in USD